188 related articles for article (PubMed ID: 31641820)
21. Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.
Zhou L; Wang W; Dicker DT; Humphreys RC; El-Deiry WS
Cancer Biol Ther; 2011 Aug; 12(4):335-48. PubMed ID: 21785270
[TBL] [Abstract][Full Text] [Related]
22. Novel pyrrolopyrimidine derivatives induce p53-independent apoptosis via the mitochondrial pathway in colon cancer cells.
Kilic-Kurt Z; Aka Y; Kutuk O
Chem Biol Interact; 2020 Oct; 330():109236. PubMed ID: 32866467
[TBL] [Abstract][Full Text] [Related]
23. Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells.
Gasparian ME; Bychkov ML; Yagolovich AV; Dolgikh DA; Kirpichnikov MP
Biochemistry (Mosc); 2015 Aug; 80(8):1080-91. PubMed ID: 26547077
[TBL] [Abstract][Full Text] [Related]
24. miR-128 Targets the SIRT1/ROS/DR5 Pathway to Sensitize Colorectal Cancer to TRAIL-Induced Apoptosis.
Lian B; Yang D; Liu Y; Shi G; Li J; Yan X; Jin K; Liu X; Zhao J; Shang W; Zhang R
Cell Physiol Biochem; 2018; 49(6):2151-2162. PubMed ID: 30257253
[TBL] [Abstract][Full Text] [Related]
25. Bigelovin triggered apoptosis in colorectal cancer in vitro and in vivo via upregulating death receptor 5 and reactive oxidative species.
Li M; Song LH; Yue GG; Lee JK; Zhao LM; Li L; Zhou X; Tsui SK; Ng SS; Fung KP; Tan NH; Lau CB
Sci Rep; 2017 Feb; 7():42176. PubMed ID: 28181527
[TBL] [Abstract][Full Text] [Related]
26. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
[TBL] [Abstract][Full Text] [Related]
27. Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells.
Park YL; Ha SY; Park SY; Choi JH; Jung MW; Myung DS; Kim HS; Joo YE
Int J Oncol; 2019 May; 54(5):1875-1883. PubMed ID: 30864676
[TBL] [Abstract][Full Text] [Related]
28. Resistance to 3-HTMC-Induced Apoptosis Through Activation of PI3K/Akt, MEK/ERK, and p38/COX-2/PGE
Semaan J; Pinon A; Rioux B; Hassan L; Limami Y; Pouget C; Fagnère C; Sol V; Diab-Assaf M; Simon A; Liagre B
J Cell Biochem; 2016 Dec; 117(12):2875-2885. PubMed ID: 27192488
[TBL] [Abstract][Full Text] [Related]
29. Modulating Survivin as a Radioresistant Factor, Caspase-3, and Apoptosis by Omega-3 Docosahexaenoic Acid Sensitizes Mutant-p53 Colorectal Cancer Cells to γ-Irradiation.
Hosseini F; Sam MR; Jabbari N; Mozdarani H
Cancer Biother Radiopharm; 2018 Nov; 33(9):387-395. PubMed ID: 30395490
[TBL] [Abstract][Full Text] [Related]
30. Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells.
Bottone FG; Baek SJ; Nixon JB; Eling TE
J Nutr; 2002 Apr; 132(4):773-8. PubMed ID: 11925476
[TBL] [Abstract][Full Text] [Related]
31. Anticancer activities of a benzimidazole compound through sirtuin inhibition in colorectal cancer.
Tan YJ; Lee YT; Yeong KY; Petersen SH; Kono K; Tan SC; Oon CE
Future Med Chem; 2018 Sep; 10(17):2039-2057. PubMed ID: 30066578
[TBL] [Abstract][Full Text] [Related]
32. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
33. High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer.
De Miguel D; Gallego-Lleyda A; Ayuso JM; Pejenaute-Ochoa D; Jarauta V; Marzo I; Fernández LJ; Ochoa I; Conde B; Anel A; Martinez-Lostao L
Cancer Lett; 2016 Dec; 383(2):250-260. PubMed ID: 27725224
[TBL] [Abstract][Full Text] [Related]
34. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
Liu HF; Hsiao PW; Chao JI
Chem Biol Interact; 2008 Oct; 176(1):48-57. PubMed ID: 18760266
[TBL] [Abstract][Full Text] [Related]
35. TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor.
Nahacka Z; Svadlenka J; Peterka M; Ksandrova M; Benesova S; Neuzil J; Andera L
Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):522-531. PubMed ID: 29278689
[TBL] [Abstract][Full Text] [Related]
36. The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis.
Meng RD; McDonald ER; Sheikh MS; Fornace AJ; El-Deiry WS
Mol Ther; 2000 Feb; 1(2):130-44. PubMed ID: 10933923
[TBL] [Abstract][Full Text] [Related]
37. The novel anthraquinone derivative IMP1338 induces death of human cancer cells by p53-independent S and G2/M cell cycle arrest.
Choi HK; Ryu H; Son AR; Seo B; Hwang SG; Song JY; Ahn J
Biomed Pharmacother; 2016 Apr; 79():308-14. PubMed ID: 27044842
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol analogue, (E)-N-(2-(4-methoxystyryl) phenyl) furan-2-carboxamide induces G
Cheah FK; Leong KH; Thomas NF; Chin HK; Ariffin A; Awang K
Apoptosis; 2018 Jun; 23(5-6):329-342. PubMed ID: 29754265
[TBL] [Abstract][Full Text] [Related]
39. Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways.
Huang GM; Sun Y; Ge X; Wan X; Li CB
World J Gastroenterol; 2015 May; 21(20):6194-205. PubMed ID: 26034354
[TBL] [Abstract][Full Text] [Related]
40. Involvement of ERK1/2-mediated ELK1/CHOP/DR5 pathway in 6-(methylsulfinyl)hexyl isothiocyanate-induced apoptosis of colorectal cancer cells.
Yano S; Wu S; Sakao K; Hou DX
Biosci Biotechnol Biochem; 2019 May; 83(5):960-969. PubMed ID: 30730256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
